Physician profile
Dylan Leon Hatfield
NPI 1972813855
$3,894.46
in general payments reported to CMS, 2019-2025
20 companies · $586 in 2025
The $586 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $52.91 · 2021: $1,854 · 2022: $247 · 2023: $359 · 2024: $302 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,222 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,221.82 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,676.54 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $434.91 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $270.42 | 2019-2023 | Cequa |
| Alcon Vision LLC | $224.79 | 2023-2025 | Hydrus Microstent, Tryptyr, Contoura Vision |
| Biotissue Holdings INC. | $164.57 | 2024-2025 | |
| Sight Sciences, INC. | $159.68 | 2021-2022 | |
| Rxsight INC | $127.48 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Bausch & Lomb Americas INC. | $117.61 | 2023-2025 | Xiidra, Miebo |
| Tarsus Pharmaceuticals, INC. | $111.36 | 2024 | Xdemvy |
| Harrow Eye, LLC | $110.23 | 2025 | |
| Abbvie INC. | $107.10 | 2022-2025 | |
| Allergan, INC. | $100.95 | 2022 | |
| Coopervision INC. | $73.83 | 2019 | |
| Dompe US, INC. | $61.19 | 2025 | Oxervate |
| Horizon Therapeutics Plc | $55.97 | 2023 | Tepezza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $24.84 | 2021 | |
| Kala Pharmaceuticals, INC. | $24.60 | 2022 | |
| Rayner Intraocular Lenses Limited | $18.97 | 2024 | Rayone Spheric, Rayner Cataract Set 1, Rayone Aspheric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.92 | 2019 | |
| Shire North American Group INC | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Hatfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.